SSA
CO

Schonfeld Strategic Advisors’s Global Cord Blood Corporation CO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,400
Closed -$124K – 2552
2021
Q1 		$124K Sell
27,400
-5,500
-17% -$23.9K ﹤0.01% 1603
2020
Q4 		$122K Sell
32,900
-7,000
-18% -$26.9K ﹤0.01% 1423
2020
Q3 		$142K Buy
+39,900
New +$138K ﹤0.01% 1243

Other funds holding CO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Schonfeld Strategic Advisors's CO Position: Q2 2021 in Review

Schonfeld Strategic Advisors sold out of Global Cord Blood Corporation (CO) in Q2 2021, closing a stake of 27,400 shares — an estimated $124K sold.

Schonfeld Strategic Advisors first reported a position in CO in Q3 2020 and held it in 3 quarters. The position peaked at $142K in Q3 2020. 31 funds tracked by Wall St. Rank hold CO as of Q2 2021.

  • Schonfeld Strategic Advisors reported no remaining Global Cord Blood Corporation position as of Q2 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 27,400 Global Cord Blood Corporation shares in Q2 2021, an estimated $124K.
  • Schonfeld Strategic Advisors first reported a position in Global Cord Blood Corporation in Q3 2020 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Global Cord Blood Corporation position peaked at $142K in Q3 2020.
  • 31 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.